Jinhe Biotechnology Co Ltd (002688) — Working Capital to Net Assets Ratio
Jinhe Biotechnology Co Ltd (002688) has a Working Capital to Net Assets ratio of -4.7% as of September 2025. Working capital of CN¥-122.22 Million (current assets of CN¥1.92 Billion minus current liabilities of CN¥2.04 Billion) is measured against net assets of CN¥2.60 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how leveraged is Jinhe Biotechnology Co Ltd's balance sheet to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Jinhe Biotechnology Co Ltd Working Capital to Net Assets (2008–2024)
This chart shows how Jinhe Biotechnology Co Ltd's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2008 to 2024. As of September 2025, the ratio stands at -4.7%, reflecting working capital of CN¥-122.22 Million against net assets of CN¥2.60 Billion CNY. Check Jinhe Biotechnology Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Jinhe Biotechnology Co Ltd (2008–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Jinhe Biotechnology Co Ltd from 2008 to 2024, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Jinhe Biotechnology Co Ltd market cap and net worth.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 6.4% | CN¥159.49 Million | CN¥2.50 Billion | CN¥2.02 Billion | CN¥1.86 Billion | ▲ +15.0 pp |
| 2023 | -8.7% | CN¥-217.74 Million | CN¥2.52 Billion | CN¥2.04 Billion | CN¥2.26 Billion | ▼ -12.0 pp |
| 2022 | 3.4% | CN¥81.88 Million | CN¥2.43 Billion | CN¥1.75 Billion | CN¥1.66 Billion | ▼ -14.7 pp |
| 2021 | 18.0% | CN¥486.27 Million | CN¥2.70 Billion | CN¥1.65 Billion | CN¥1.16 Billion | ▲ +25.6 pp |
| 2020 | -7.6% | CN¥-132.91 Million | CN¥1.75 Billion | CN¥1.24 Billion | CN¥1.37 Billion | ▼ -12.9 pp |
| 2019 | 5.3% | CN¥95.37 Million | CN¥1.81 Billion | CN¥1.24 Billion | CN¥1.15 Billion | ▼ -6.7 pp |
| 2018 | 12.0% | CN¥212.81 Million | CN¥1.78 Billion | CN¥1.32 Billion | CN¥1.10 Billion | ▼ -1.8 pp |
| 2017 | 13.8% | CN¥225.18 Million | CN¥1.64 Billion | CN¥1.08 Billion | CN¥855.12 Million | ▼ -7.5 pp |
| 2016 | 21.2% | CN¥336.15 Million | CN¥1.58 Billion | CN¥865.20 Million | CN¥529.05 Million | ▲ +22.2 pp |
| 2015 | -1.0% | CN¥-10.05 Million | CN¥1.05 Billion | CN¥801.94 Million | CN¥811.99 Million | ▼ -57.3 pp |
| 2014 | 56.4% | CN¥538.86 Million | CN¥956.13 Million | CN¥764.88 Million | CN¥226.02 Million | ▲ +3.6 pp |
| 2013 | 52.8% | CN¥475.13 Million | CN¥900.07 Million | CN¥575.23 Million | CN¥100.10 Million | ▼ -10.6 pp |
| 2012 | 63.4% | CN¥547.54 Million | CN¥863.55 Million | CN¥669.89 Million | CN¥122.36 Million | ▲ +60.5 pp |
| 2011 | 2.9% | CN¥9.79 Million | CN¥334.40 Million | CN¥324.95 Million | CN¥315.16 Million | ▲ +16.2 pp |
| 2010 | -13.3% | CN¥-33.80 Million | CN¥254.83 Million | CN¥272.60 Million | CN¥306.40 Million | ▲ +38.7 pp |
| 2009 | -51.9% | CN¥-101.80 Million | CN¥196.03 Million | CN¥304.87 Million | CN¥406.67 Million | ▲ +16.7 pp |
| 2008 | -68.6% | CN¥-122.05 Million | CN¥177.82 Million | CN¥249.85 Million | CN¥371.90 Million | — |